Glioblastoma multiforme: A rare case of GBM

The most rapid and severe primary brain tumor in adults is Glioblastoma Multiforme (GBM), which is known for its rapid development and high invasiveness. GBM is still associated with a dismal prognosis, even with advancements in multiple treatment modalities like chemotherapy, radiotherapy, and surg...

Full description

Saved in:
Bibliographic Details
Main Authors: Albert Paul Varghese, Anurag Luharia, Ashish Uke, Monika Luharia, Gaurav Mishra, Sneha Shrungare, Neha Rahul
Format: Article
Language:English
Published: Krishna Vishwa Vidyapeeth (Deemed to be University), Karad 2024-10-01
Series:Journal of Krishna Institute of Medical Sciences University
Subjects:
Online Access:https://www.jkimsu.com/jkimsu-vol13no4/JKIMSU,%20Vol.%2013,%20No.%204,%20October-December%202024%20Page%20189-193.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849391509511602176
author Albert Paul Varghese
Anurag Luharia
Ashish Uke
Monika Luharia
Gaurav Mishra
Sneha Shrungare
Neha Rahul
author_facet Albert Paul Varghese
Anurag Luharia
Ashish Uke
Monika Luharia
Gaurav Mishra
Sneha Shrungare
Neha Rahul
author_sort Albert Paul Varghese
collection DOAJ
description The most rapid and severe primary brain tumor in adults is Glioblastoma Multiforme (GBM), which is known for its rapid development and high invasiveness. GBM is still associated with a dismal prognosis, even with advancements in multiple treatment modalities like chemotherapy, radiotherapy, and surgical resection. The typical survival following diagnosis is only 12 to 15 months. GBM is incredibly heterogeneous due to its complicated genetic and molecular causes, which makes effective therapy very challenging. Three key molecular pathways associated with the pathophysiology of GBM include PI3K/AKT/mTOR, Rb signaling, and the p53 tumor suppressor. There are promising prospects to improve clinical outcomes with new treatment techniques that target these pathways in addition to innovative strategies like immunotherapy and personalized medicine. This research investigates characteristic approaches to GBM management which includes post op adjuvant radiotherapy with concurrent temozolomide followed by adjuvant chemotherapy for 6 to 12 cycles.
format Article
id doaj-art-cf55c63a8fe14f209a1d045e7a39566a
institution Kabale University
issn 2231-4261
language English
publishDate 2024-10-01
publisher Krishna Vishwa Vidyapeeth (Deemed to be University), Karad
record_format Article
series Journal of Krishna Institute of Medical Sciences University
spelling doaj-art-cf55c63a8fe14f209a1d045e7a39566a2025-08-20T03:41:03ZengKrishna Vishwa Vidyapeeth (Deemed to be University), KaradJournal of Krishna Institute of Medical Sciences University2231-42612024-10-01134189193Glioblastoma multiforme: A rare case of GBMAlbert Paul Varghese0Anurag Luharia1Ashish Uke2Monika Luharia3Gaurav Mishra4Sneha Shrungare5Neha Rahul6Department of Radio-diagnosis, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaDepartment of Radio-Therapy, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaDepartment of Radio-Therapy, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaDepartment of Ayurveda, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaDepartment of Radio-diagnosis, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaSchool of Allied Health Science, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaDepartment of Radio-Therapy, Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha-442001 (Maharashtra) IndiaThe most rapid and severe primary brain tumor in adults is Glioblastoma Multiforme (GBM), which is known for its rapid development and high invasiveness. GBM is still associated with a dismal prognosis, even with advancements in multiple treatment modalities like chemotherapy, radiotherapy, and surgical resection. The typical survival following diagnosis is only 12 to 15 months. GBM is incredibly heterogeneous due to its complicated genetic and molecular causes, which makes effective therapy very challenging. Three key molecular pathways associated with the pathophysiology of GBM include PI3K/AKT/mTOR, Rb signaling, and the p53 tumor suppressor. There are promising prospects to improve clinical outcomes with new treatment techniques that target these pathways in addition to innovative strategies like immunotherapy and personalized medicine. This research investigates characteristic approaches to GBM management which includes post op adjuvant radiotherapy with concurrent temozolomide followed by adjuvant chemotherapy for 6 to 12 cycles.https://www.jkimsu.com/jkimsu-vol13no4/JKIMSU,%20Vol.%2013,%20No.%204,%20October-December%202024%20Page%20189-193.pdfglioblastoma multiformetumorcellgrowth
spellingShingle Albert Paul Varghese
Anurag Luharia
Ashish Uke
Monika Luharia
Gaurav Mishra
Sneha Shrungare
Neha Rahul
Glioblastoma multiforme: A rare case of GBM
Journal of Krishna Institute of Medical Sciences University
glioblastoma multiforme
tumor
cell
growth
title Glioblastoma multiforme: A rare case of GBM
title_full Glioblastoma multiforme: A rare case of GBM
title_fullStr Glioblastoma multiforme: A rare case of GBM
title_full_unstemmed Glioblastoma multiforme: A rare case of GBM
title_short Glioblastoma multiforme: A rare case of GBM
title_sort glioblastoma multiforme a rare case of gbm
topic glioblastoma multiforme
tumor
cell
growth
url https://www.jkimsu.com/jkimsu-vol13no4/JKIMSU,%20Vol.%2013,%20No.%204,%20October-December%202024%20Page%20189-193.pdf
work_keys_str_mv AT albertpaulvarghese glioblastomamultiformeararecaseofgbm
AT anuragluharia glioblastomamultiformeararecaseofgbm
AT ashishuke glioblastomamultiformeararecaseofgbm
AT monikaluharia glioblastomamultiformeararecaseofgbm
AT gauravmishra glioblastomamultiformeararecaseofgbm
AT snehashrungare glioblastomamultiformeararecaseofgbm
AT neharahul glioblastomamultiformeararecaseofgbm